HR 738
105th Congress
House
Health
Medical research
Medical statistics
Medical tests
Nervous system diseases
Neurology
Pain
Science, Technology, Communications
Myelogram-Related Arachnoiditis Amendments of 1997
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 24, 1997
Referred to the Subcommittee on Health and Environment.
Feb 12, 1997
Referred to the House Committee on Commerce.
Feb 12, 1997
Sponsor introductory remarks on measure. (CR E226-227)
Feb 12, 1997
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Myelogram-Related Arachnoiditis Amendments of 1997 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a myelogram involving the use of Pantopaque, Amipaque, Omipacque, or Isovue.
Amends the Public Health Service Act to require a study and research with respect to individuals who have undergone a myelogram and who have subsequently developed arachnoiditis.
What's happening now
Referred to the Subcommittee on Health and Environment.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cosponsors
2
Cite this page
U.S. Congress. (2026). H.R. 738: Myelogram-Related Arachnoiditis Amendments of 1997. 105th Congress. Open America. https://openamerica.io/bill/105-HR-738/
"H.R. 738: Myelogram-Related Arachnoiditis Amendments of 1997." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HR-738/.
H.R. 738, 105th Cong. (2026), https://openamerica.io/bill/105-HR-738/.
[H.R. 738: Myelogram-Related Arachnoiditis Amendments of 1997](https://openamerica.io/bill/105-HR-738/)